Thank you for Subscribing to Cannabis Business Insights Weekly Brief
Jason Malcolm, PrincipalMirroring the arc of a business journey, its extensive, hands-on experience provides a strategy for businesses to launch and thrive. The intricate steps Arcview follows from pre-revenue to post-revenue stages make it one of the most comprehensive cannabis consulting services.
“Licensing services are a priority for us, especially with upcoming opportunities in Minnesota, Pennsylvania, and possibly Florida. Many states, such as Ohio, have lottery-based systems, which clients can find overwhelming if they are just starting out in the cannabis business. We are dedicated to supporting such clients every step of the way,” states Jason Malcolm, Principal.
Unlocking the Potential of A-Z Cannabis Consulting
Arcview Consulting offers a comprehensive suite of services beyond licensing. These include operational support through outsourced Chief Strategy Officer roles, 90-day kick-start programs, operations optimization, risk management, business valuations, brand expansion and mergers and acquisitions. It's our deep bench that allows us to address diverse client needs, problems and challenges, offering tailored solutions that drive success and growth.
Licensing services are a priority for us, especially with upcoming opportunities in Minnesota, Pennsylvania, and possibly Florida. Many states, such as Ohio, have lottery-based systems, which clients can find overwhelming if they are just starting out in the cannabis business. We are dedicated to supporting such clients every step of the way.
As businesses flourish, new complexities emerge. For established cannabis brands expanding across state lines, maintaining product quality and consistency is crucial. Arcview’s detailed vetting process helps identify ideal contract manufacturing partners in emerging and mature states, fostering sustainable partnerships that preserve brand reputation and market presence.
Arcview also addresses operational inefficiencies through process improvements and cost-saving measures. For retail operations, the firm offers optimization techniques such as enhanced product placement and improved shelf space utilization in cannabis stores, maximizing revenue potential and market presence.
Small business loans and other traditional funding sources are largely inaccessible to most cannabis operations due to regulatory restrictions. In such scenarios, Arcview helps its clients connect with entities having similar business and financial interests to foster a mutually beneficial relationship.
Moreover, Arcview is also known for its thorough business valuations conducted by CPAs and certified business evaluators. This comprehensive approach, combined with strategic planning services, ensures clients can scale effectively and achieve sustained success.
When a business reaches the point where they need to transition or exit, Arcview remains their steadfast partner as well, facilitating the sale of their cultivation, manufacturing and retail operations. While it doesn’t handle definitive documentation and other legal aspects, it assures a smooth transaction and assists in structuring the purchase of locations by connecting sellers with buyers and coordinating legal teams.
Consider the case of an ag-tech company contemplating the acquisition of an industrial hemp firm. It engaged Arcview for comprehensive insights to inform their decision. An in-depth analysis revealed that the target company’s valuation was substantially inflated. This critical evaluation saved the client from paying too much for an asset that was unlikely to deliver a suitable return within an optimal timeframe.
Driven by these successes, Arcview is expanding beyond its primary focus on the cannabis industry and venturing into the realm of psilocybin—psychoactive mushrooms—through DEA licenses. These licenses allow for the legal cultivation, distribution, import, export and research of cannabis, psilocybin and other schedule 1-5 drugs, at the federal level. This service has gained increased relevance with the recent rescheduling of cannabis from a Schedule I to a Schedule III drug. Pharmacies will soon be able to source these substances from DEA-approved manufacturing facilities, creating the potential for insurance coverage for patients and making cannabis more accessible for medical use.
Arcview’s goal is to help clients understand the impact of regulatory changes on their businesses, particularly as insurance companies begin covering Schedule III drugs. Adapting an overarching approach, the firm advises on revenue generation through process improvement and optimization strategies. The firm also provides white glove services to its clients from the pre-revenue stage through their exit, assisting them through business-as-usual challenges that arise when operating a business.
Such comprehensiveness illustrates how the firm is not just a guide for cannabis businesses but a translator of the industry’s complex landscape, offering support throughout the entire business lifecycle.
